Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders |
Clearfield, Inc. (CLFD)
|
Add to portfolio |
|
|
Price: |
$30.37
| | Metrics |
OS: |
15.3
|
M
| |
|
|
Market cap: |
$464
|
M
| |
|
|
Net cash:
|
$166
|
M
| |
$10.91
|
per share
|
EV:
|
$297
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
Revenues | 270.9 | 140.8 | 93.1 | 85.0 | 77.7 | 73.9 | 75.3 | 60.3 |
Revenue growth | 92.5% | 51.2% | 9.5% | 9.5% | 5.0% | -1.8% | 24.8% | 3.9% |
Cost of goods sold | 157.9 | 79.6 | 55.2 | 52.3 | 46.7 | 43.7 | 42.4 | 35.5 |
Gross profit | 112.9 | 61.2 | 37.9 | 32.7 | 31.0 | 30.3 | 32.9 | 24.9 |
Gross margin | 41.7% | 43.5% | 40.7% | 38.4% | 39.9% | 40.9% | 43.7% | 41.2% |
Selling, general and administrative | 49.1 | 35.9 | 29.5 | 27.5 | 25.9 | 25.0 | 22.1 | 17.8 |
Research and development | | | | | | | | |
EBITA | 64.6 | 25.8 | 8.9 | 5.7 | 5.4 | 5.3 | 10.7 | 7.1 |
EBITA margin | 23.8% | 18.4% | 9.5% | 6.7% | 6.9% | 7.2% | 14.3% | 11.7% |
Amortization of intangibles | 0.8 | 0.6 | 0.5 | 0.5 | 0.3 | 0.0 | 0.0 | |
EBIT | 63.8 | 25.2 | 8.4 | 5.2 | 5.1 | 5.3 | 10.7 | 7.1 |
EBIT margin | 23.6% | 17.9% | 9.0% | 6.1% | 6.5% | 7.2% | 14.3% | 11.7% |
Pre-tax income | 63.8 | 25.7 | 9.2 | 5.9 | 5.5 | 5.6 | 10.9 | 7.2 |
Income taxes | 14.5 | 5.4 | 1.9 | 1.4 | 1.3 | 1.7 | 2.9 | 2.5 |
Tax rate | 22.7% | 21.0% | 20.3% | 23.0% | 22.7% | 31.1% | 26.4% | 34.6% |
Net income | 49.4 | 20.3 | 7.3 | 4.6 | 4.3 | 3.8 | 8.0 | 4.7 |
Net margin | 18.2% | 14.4% | 7.8% | 5.4% | 5.5% | 5.2% | 10.6% | 7.8% |
|
Diluted EPS | $3.55 | $1.47 | $0.53 | $0.34 | $0.32 | $0.28 | $0.59 | $0.34 |
Shares outstanding (diluted) | 13.9 | 13.8 | 13.6 | 13.5 | 13.5 | 13.7 | 13.7 | 13.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|